BOSTON--(BUSINESS WIRE)-- PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that its Founded Entity, Vedanta Biosciences, today announced the appointment of Troy Ignelzi as an independent member of its Board of Directors...

SANTA CLARA, Calif., Nov. 12, 2020 /PRNewswire/ -- Semler Scientific Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced the appointment of Cindy Moon, a D.C.-based, healthcare payment policy expert, to its Board of Directors...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced the appointment of Gail M. Farfel, Ph.D., to its Board of Directors...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River LaboratoriesInternational, Inc. (NYSE: CRL) today announced the appointment of George Llado, Senior Vice President and Chief Information Officer of Alexion Pharmaceuticals, Inc., to its Board of Directors...

SAN DIEGO, Oct. 7, 2020 /PRNewswire/ -- MedCrypt Inc., the leading provider of proactive security solutions for the healthcare space, today announced the addition of Michael McNeil to its board of directors...

SAN DIEGO--(BUSINESS WIRE)-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Elizabeth (Betsy) Garofalo, M.D. to its Board of Directors...

MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appointment of Lisa Giles and Robert Wills to its Board of Directors...

Zogenix (Nasdaq: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced the appointments of Caroline M. Loewy, Mary E. Stutts and Denelle J. Waynick to newly created seats on its Board of Directors...

BEDMINSTER, N.J., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced the appointment of Natasha Giordano to its Board of Directors...

Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, appointed Stephen Davis, the Chairman and Founder of the Will Group, to the Company's Board of Directors...

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the appointment of President and CEO Justin Hall to the Company’s board of directors...

NEW YORK, NY / ACCESSWIRE / August 13, 2020 / Kadmon, Inc. (NYSE:KDMN) today announced the appointment of Nancy Miller-Rich to its Board of Directors...

Protagonist Therapeutics, Inc., Inc. (Nasdaq:PTGX) today announced the appointment of Sarah O'Dowd as an independent director to the Protagonist Board of Directors. Ms. O'Dowd brings broad experience in management and corporate governance to Protagonist, including senior level oversight in the biopharmaceutical industry. In connection with the appointment, Chaitan Khosla, Ph.D., Professor of Chemistry and Engineering at Stanford University, is stepping down from his position on the board...

Meridian Bioscience (see Meridan Life Science) Inc. (NASDAQ: VIVO) announces the appointment of Anthony Bihl III to its Board of Directors, effective immediately...

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs, today announced the appointment of Barry P. Flannelly, Pharm.D, to its Board of Directors...

PRNewswire/ -- Today Berkeley Lights, Inc., a leader in Digital Cell Biology, announced the appointment of Gregory T. Lucier to the Berkeley Lights Board of Directors. An established thought leader in the life sciences industry, Mr. Lucier has over 25 years of experience in developing and growing innovation-driven companies into market leaders, with expertise in contemporary corporate governance..

Inozyme Pharma, Inc., a rare disease biopharmaceutical company developing novel therapeutics for the treatment of disorders of abnormal mineralization, announced today the appointment of Doug Treco, Ph.D., as Chairman of the Company’s Board of Directors...

SOUTH SAN FRANCISCO, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc.. (NGM) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced the appointment of Carole Ho, M.D. to its Board of Directors...

TAMPA, Fla.--(BUSINESS WIRE)-- Oragenics, Inc. (NYSE American: OGEN)(“Oragenics” or the “Company”), today announced that it has increased the size of its board of directors and appointed Ms. Kim Murphy to the board...

BOSTON, April 17, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, announced the election of Michael Coyle to its Board of Directors...

CAMBRIDGE, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- Solid Biosciences Inc.(Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy, announced today the appointment of Ian F. Smith to its board of directors...

DURHAM, N.C., March 11, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences Inc. (Nasdaq: DTIL), a life sciences company dedicated to improving life through the application of its pioneering, proprietary ARCUS® genome editing platform, announced today that Geno Germano, President and CEO of Elucida Oncology, has been appointed to the company’s Board of Directors...

NEW YORK--(BUSINESS WIRE)--Pfizer, Inc.. (NYSE: PFE) today announced the election of Dr. Susan Hockfield to its Board of Directors, effective immediately...